MECOM
protein-codingMDS1 and EVI1 complex locus, the group of PR/SET domain family|Lysine methyltransferases|Zinc fingers C2H2-type
Gene summary
The protein encoded by this gene is a transcriptional regulator and oncoprotein that may be involved in hematopoiesis, apoptosis, development, and cell differentiation and proliferation. The encoded protein can interact with CTBP1, SMAD3, CREBBP, KAT2B, MAPK8, and MAPK9. This gene can undergo translocation with the AML1 gene, resulting in overexpression of this gene and the onset of leukemia. Several transcript variants encoding a few different isoforms have been found for this gene. [provided by RefSeq, Mar 2011]
- MDS1
- EVI1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~580.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0011555
Submitter: Orphanet
Inheritance Pattern: AD
Disease ID:MONDO:0014758
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0014758
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014758
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014758
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0100458
Submitter: ClinGen
MECOM was first reported in relation to Autosomal dominant MECOM-associated syndrome in 2015 (Niihori et al., PMID:26581901). This is a syndromic disease with a variable phenotypic pattern, ranging from isolated radioulnar synostosis with no or mild hematological involvement to severe bone marrow failure without obvious skeletal abnormalities. The clinical picture can also include clinodactyly, cardiac and renal malformations, B-cell deficiency, amegakaryocytic thrombocytopenia, and presenile hearing loss. MECOM codes for a zinc finger transcription factor with important roles in normal development and oncogenesis. The MECOM locus encodes a number of differentially spliced transcripts yielding the MDS1, MDS1-EVI1, and EVI1 protein isoforms. At least 10 missense variants and 5 predicted null variants have been reported in humans. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 16 probands in 4 publications (PMID: 26581901, 29519864, 29540340, 29097497). The mechanism for disease may be haploinsufficiency. This gene-disease association is supported by expression studies consistent with roles in bone marrow (PMID: 22084405) and limb development (PMID: 1893871) and mouse models with partial recapitulation of phenotypes (PMIDs: 24586749, 17029558). In summary, MECOM is definitively associated with Autosomal Dominant MECOM-associated syndrome. This has been repeatedly demonstrated in research and has been upheld over time.
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Hematologic; Musculoskeletal
Intervention: Allergy/Immunology/Infectious; Hematologic
Rationale: The condition involves bone marrow failure, and awareness may allow prompt management of hematologic complications as well as complications related to susceptibility to infections; HSCT has been described
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MECOM variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_004991.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 572 | 2 | 577 | ||
| missense | 7 | 15 | 1213 | 51 | 1286 | |
| nonsense | 5 | 3 | 3 | 11 | ||
| start loss | 0 | |||||
| frameshift | 4 | 2 | 6 | |||
| splice donor/acceptor (+/-2bp) | 2 | 1 | 6 | 9 | ||
| Total | 18 | 21 | 1225 | 623 | 2 | 1889 |
Highest pathogenic variant AF is 0.000014443806
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_004982.2 | 17 | MANE Select | |
| Ensembl | ENSP00000498411.1 | 17 | MANE Select | |
| RefSeq | NP_001098547.3 | 16 | Standard | |
| RefSeq | NP_001098548.2 | 14 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| mecom | Danio rerio | Structure: ventral wall of dorsal aorta Quality: decreased amount abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Chronic myeloid leukemia - Homo sapiens (human)
- MAPK signaling pathway - Homo sapiens (human)
- Pathways in cancer - Homo sapiens (human)
- White fat cell differentiation
- White fat cell differentiation
Biological Process
- regulation of transcription by RNA polymerase II
- apoptotic process
- cell differentiation
- histone lysine methylation
- negative regulation of programmed cell death
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA binding
- DNA-binding transcription factor activity
- protein binding
- histone-lysine N-methyltransferase activity
Cellular Component
- histone deacetylase complex
- nucleus
- nucleoplasm
- cytosol
- nuclear speck
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000264674
- Coding exons
- 16
- Length
- 580120
- Individuals with no LoFs
- 125726
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 7
- Defined
- 125733
- p
- 0.0000278
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.62 | 496 | 608 | 0.815 | 0.0000316 | 7461 |
| Missense (PolyPhen) | 177 | 255.63 | 0.69239 | 3150 | ||
| Synonymous | -1.28 | 252 | 227 | 1.11 | 0.0000131 | 2018 |
| Loss of Function | 6.02 | 2 | 46.1 | 0.0433 | 0.00000216 | 626 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000053 | 0.000053 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Isoform 1: Functions as a transcriptional regulator binding to DNA sequences in the promoter region of target genes and regulating positively or negatively their expression. Oncogene which plays a role in development, cell proliferation and differentiation. May also play a role in apoptosis through regulation of the JNK and TGF-beta signaling. Involved in hematopoiesis. {ECO:0000269|PubMed:10856240, ECO:0000269|PubMed:11568182, ECO:0000269|PubMed:15897867, ECO:0000269|PubMed:16462766, ECO:0000269|PubMed:19767769, ECO:0000269|PubMed:9665135}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving EVI1 is a cause of chronic myelogenous leukemia (CML). Translocation t(3;21)(q26;q22) with RUNX1/AML1. {ECO:0000269|PubMed:8313895}.; DISEASE: Radioulnar synostosis with amegakaryocytic thrombocytopenia 2 (RUSAT2) [MIM:616738]: An autosomal dominant disease characterized by proximal fusion of the radius and ulna resulting in extremely limited pronation and supination of the forearm, and congenital thrombocytopenia that progresses to pancytopenia. {ECO:0000269|PubMed:26581901}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Note=A chromosomal aberration involving MDS1 is found in a form of acute myeloid leukemia (AML). Translocation t(3;21) with AML1. {ECO:0000269|PubMed:8643684}.;
Recessive Scores
- pRec
- 0.302
Intolerance Scores
- RVIS EVS
- -0.99
- RVIS percentile EVS
- 8.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.450
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |